The Technical Analyst
Kraig Biocraft [KBLB]
Exchange: PNK Industry: Specialty Chemicals
Kraig Biocraft Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.33% $0.0930
America/New_York / 3 mai 2024 @ 15:57
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 96.57 mill |
| EPS: | -0.0100 |
| P/E: | -9.30 |
| Earnings Date: | May 10, 2024 |
| SharesOutstanding: | 1 038.37 mill |
| Avg Daily Volume: | 1.647 mill |
| RATING 2024-05-03 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -9.30 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -9.30 | industry: PE -45.81 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.0007 (-99.23%) $-0.0923 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0810 - 0.105 ( +/- 12.90%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-02-16 | Rice Jonathan Richard | Buy | 2 434 211 | Class A Common Stock Option |
| 2022-07-19 | Thompson Kimberly Kraig | Sell | 120 000 | Common Stock |
| 2022-07-15 | Thompson Kimberly Kraig | Sell | 79 900 | Common Stock |
| 2022-07-13 | Thompson Kimberly Kraig | Sell | 11 500 | Common Stock |
| 2022-07-11 | Thompson Kimberly Kraig | Sell | 100 000 | Common Stock |
| INSIDER POWER |
|---|
| -10.97 |
| Last 80 transactions |
| Buy: 4 006 771 | Sell: 12 826 343 |
Forecast:
16:00 - $0.0930
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.0930
Forecast 2: 16:00 - $0.0930
Forecast 3: 16:00 - $0.0930
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0930 (3.33% ) |
| Volume | 0.410 mill |
| Avg. Vol. | 1.647 mill |
| % of Avg. Vol | 24.89 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For KBLB
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
KBLB
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company's products are used in military and police applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
Latest Press Releases
2024-04-29 07:05:00 - Press Release
Kraig Biocraft Laboratories Reports Signing Landmark Agreements In South East Asia
Ann arbor, mich., april 29, 2024 (globe newswire) -- kraig biocraft laboratories, inc. (otcqb: kblb) ("the company"), announces today that it has signed key agreements with the lam dong agro-forestry research experiment center ("larec"), the sericulture authority in central vietnam, pertaining to the rearing and breeding of the company's specialized silkworm.
2024-04-22 07:05:00 - Press Release
Kraig Biocraft Laboratories Successfully Completes Recombinant Cocoon Production From Spring Trials
Kraig labs (otcqb: kblb) achieves major milestone; completes new bam-1 1st gen parental strain rearing and cocoons at rates that exceeded expectations
2024-04-15 07:05:00 - Press Release
Kraig Biocraft Laboratories Announces Successful Launch Of Spring Production Trials In Southeast Asia For Spider Silk
Ann arbor, mich., april 15, 2024 (globe newswire) -- kraig biocraft laboratories, inc. (otcqb: kblb) ("the company" or "kraig labs"), announces today that the spring production trials for the new bam-1 hybrid have begun and are well on track to meet the company's expectations and timeline.
2024-04-08 07:05:00 - Press Release
Kraig Biocraft Laboratories Signs Landmark Agreement In Vietnam's Silk Production Capital
Ann arbor, mich., april 08, 2024 (globe newswire) -- kraig biocraft laboratories, inc. (otcqb: kblb) ("the company" or "kraig labs"), announces today that it has signed a landmark agreement with the vietnam sericulture association ("vsa").
2024-03-28 07:05:00 - Press Release
Kraig Biocraft Laboratories Shares Industry Update On Recombinant Spider Silk From Waste Plastics
Ann arbor, mich., march 28, 2024 (globe newswire) -- kraig biocraft laboratories, inc. (otcqb: kblb) ("kraig labs" or "the company"), comments on an exciting advancement in spider silk engineering from the rensselaer polytechnic institute ("rpi").
Latest News
2021-10-19 07:05:00 - GlobeNewsWire
Challenge Testing of Kraig Biocraft Laboratories' Disease Resistant Silkworms Underway
Immunity enhanced silkworms provide licensing opportunities into the broader $14B1 silk industry
2021-10-12 07:05:00 - GlobeNewsWire
Kraig Biocraft Laboratories Announces Breakthrough in Creation of New Recombinant Spider Silks
Kraig Labs files provisional patent for next-generation gene-editing system Kraig Labs files provisional patent for next-generation gene-editing system
2021-09-28 07:05:00 - GlobeNewsWire
Kraig Biocraft Laboratories Prepares for Challenge Testing of Disease Resistant Silkworm Lines
Immunity enhanced silkworms provide licensing opportunities into the broader $14 B 1 silk industry
2021-09-23 07:05:00 - GlobeNewsWire
Kraig Biocraft Laboratories Delivers First Sample Fabrics to Spydasilk Enterprises
ANN ARBOR, Mich., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces today that it has delivered the first fabric samples to Spydasilk Enterprises (“Spydasilk”). These fabric blends will serve as the basis for developing the Company's first line of recombinant spider silk apparel.
2021-09-08 07:05:00 - GlobeNewsWire
Kraig Biocraft Laboratories Creates Second Generation of Recombinant Spider Silk Silkworms at New Production Headquarters
Follows Prodigy's successful First Batch at New Facility in August Follows Prodigy's successful First Batch at New Facility in August
2021-08-27 07:05:00 - GlobeNewsWire
Kraig Biocraft Laboratories Adds European Union to Ever-growing Portfolio of Spider Silk Patents
ANN ARBOR, Mich., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today that it has been granted patent protection for its recombinant spider silk technologies in the European Union.
2021-08-17 07:05:00 - GlobeNewsWire
Kraig Biocraft Laboratories Completes Transition of Production Operations to Custom Designed Silk Rearing Facility
Kraig Labs takes possession of silkworm rearing and breeding facility in the heart of Vietnamese agriculture district Kraig Labs takes possession of silkworm rearing and breeding facility in the heart of Vietnamese agriculture district
2021-08-10 07:05:00 - GlobeNewsWire
Kraig Biocraft Laboratories Welcomes New Senior Scientist
ANN ARBOR, Mich., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today the expansion of its development team with the addition of a new senior scientist. Dr. Jimi Miller joined the Kraig Labs team in July and has hit the ground running, bringing new ideas and excitement to the research team.
2021-08-05 07:05:00 - GlobeNewsWire
Kraig Biocraft Laboratories Expands Intellectual Property Portfolio
ANN ARBOR, Mich., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk based fibers, announces today that the Company has further expanded its leading position in the development of recombinant spider silk with the filing of two new patent applications. These new innovative patents build upon underlying knock-in/knock-out gene-editing technologies that the Company first made public in 2020.
2021-07-27 07:05:00 - GlobeNewsWire
Kraig Biocraft Laboratories provides Spider Silk Production Update
ANN ARBOR, Mich., July 27, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, today provides updates concerning the Company's spider silk production program and the impacts to its operations of the tightening COVID-19 restrictions in Vietnam and globally.